These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Polymorphism in promoter region of inducible nitric oxide synthase gene and protection against malaria. Kun JF; Mordmüller B; Lell B; Lehman LG; Luckner D; Kremsner PG Lancet; 1998 Jan; 351(9098):265-6. PubMed ID: 9457101 [No Abstract] [Full Text] [Related]
4. Nitric oxide synthase type 2 promoter polymorphisms, nitric oxide production, and disease severity in Tanzanian children with malaria. Levesque MC; Hobbs MR; Anstey NM; Vaughn TN; Chancellor JA; Pole A; Perkins DJ; Misukonis MA; Chanock SJ; Granger DL; Weinberg JB J Infect Dis; 1999 Dec; 180(6):1994-2002. PubMed ID: 10558957 [TBL] [Abstract][Full Text] [Related]
5. Question. Do NOS2 promoter polymorphisms protect against malaria? Ascenzi P; Gradoni L; Visca P IUBMB Life; 2004 Apr; 56(4):229-30. PubMed ID: 15230351 [No Abstract] [Full Text] [Related]
6. Age-dependent effect of plasma nitric oxide on parasite density in Ghanaian children with severe malaria. Cramer JP; Nüssler AK; Ehrhardt S; Burkhardt J; Otchwemah RN; Zanger P; Dietz E; Gellert S; Bienzle U; Mockenhaupt FP Trop Med Int Health; 2005 Jul; 10(7):672-80. PubMed ID: 15960706 [TBL] [Abstract][Full Text] [Related]
7. A new NOS2 promoter polymorphism associated with increased nitric oxide production and protection from severe malaria in Tanzanian and Kenyan children. Hobbs MR; Udhayakumar V; Levesque MC; Booth J; Roberts JM; Tkachuk AN; Pole A; Coon H; Kariuki S; Nahlen BL; Mwaikambo ED; Lal AL; Granger DL; Anstey NM; Weinberg JB Lancet; 2002 Nov; 360(9344):1468-75. PubMed ID: 12433515 [TBL] [Abstract][Full Text] [Related]
8. Significant association of longer forms of CCTTT Microsatellite repeat in the inducible nitric oxide synthase promoter with severe malaria in Thailand. Ohashi J; Naka I; Patarapotikul J; Hananantachai H; Looareesuwan S; Tokunaga K J Infect Dis; 2002 Aug; 186(4):578-81. PubMed ID: 12195390 [TBL] [Abstract][Full Text] [Related]
9. Tissue distribution of migration inhibitory factor and inducible nitric oxide synthase in falciparum malaria and sepsis in African children. Clark IA; Awburn MM; Whitten RO; Harper CG; Liomba NG; Molyneux ME; Taylor TE Malar J; 2003 Apr; 2():6. PubMed ID: 12716455 [TBL] [Abstract][Full Text] [Related]
10. Migration inhibitory factor in the cerebral and systemic endothelium in sepsis and malaria. Clark I; Awburn M Crit Care Med; 2002 May; 30(5 Suppl):S263-7. PubMed ID: 12004246 [TBL] [Abstract][Full Text] [Related]
16. High levels of inducible nitric oxide synthase mRNA are associated with increased monocyte counts in blood and have a beneficial role in Plasmodium falciparum malaria. Chiwakata CB; Hemmer CJ; Dietrich M Infect Immun; 2000 Jan; 68(1):394-9. PubMed ID: 10603415 [TBL] [Abstract][Full Text] [Related]
18. [Expression and functions of inducible nitric oxide synthase]. Tsutsui M; Ueno S; Toyohira Y; Yanagihara N Nihon Rinsho; 2004 Sep; 62 Suppl 9():460-4. PubMed ID: 15506427 [No Abstract] [Full Text] [Related]
19. Regulation of nitrogen monoxide production in human malaria. Kun JF Redox Rep; 2003; 8(5):289-91. PubMed ID: 14962367 [TBL] [Abstract][Full Text] [Related]
20. Nitric oxide suppresses inducible nitric oxide synthase expression by inhibiting post-translational modification of IkappaB. Chang K; Lee SJ; Cheong I; Billiar TR; Chung HT; Han JA; Kwon YG; Ha KS; Kim YM Exp Mol Med; 2004 Aug; 36(4):311-24. PubMed ID: 15365250 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]